BookVijay Kumar Shukla, Manoj Pandey, Ruhi Dixit, editors.
Summary: The book discusses the recent progress in understanding the therapeutic targets for gallbladder cancer to provide opportunities for research and for developing innovative strategies that may enhance the benefit of conventional chemotherapy. The book focuses on identifying candidate molecules and the overall status of the targeted therapies available for gallbladder cancer, as there is an urgent need to discover new molecular targets that can guide the emergence of new treatment strategies to improve patient outcomes and act as biomarkers for the early detection of diseases. Recently, new treatment therapeutics targets for gallbladder cancer patients have been identified and the field is evolving rapidly. The book is relevant for the clinical researcher, surgeon, scientist and academician.
Contents:
Gallbladder Cancer: Current treatment options and therapeutics
Surgical Management of Gallbladder Cancer Patients
Conventional therapy in Gallbladder Cancer
Adjuvant Therapy following Surgical Treatment of Gallbladder Cancer
Incidental gallbladder cancer: the role of routine versus selective histopathological examination of gallbladder specimens after cholecystectomy
Minimally Invasive Surgery for Management of Gallbladder Cancer
Thickwalled Gallbladder: Differential diagnosis and surgical approach to a thickened gallbladder
Management of incidentally detected gallbladder cancer after cholecystectomy
Adjuvant treatment in radically resected gallbladder cancer
A look at emerging therapeutic targets for gallbladder cancer: a multi-omics approach
MicroRNA and their role in Carcinoma Gallbladder
Gallbladder cancer: Epigenetic landscape, Targeted therapy and Prospect of Epitherapy
Targeted treatment of Gallbladder cancer
Molecular pathways in Gallbladder cancer as potential therapeutic target
Targeted Therapy: Molecular Pathology and Targets of Gallbladder Cancer
Targeted Therapies in Gallbladder Cancer: Current Status and Future Perspectives
Integrative omics - the roadmap for gallbladder biomarkers identification
Anti-EGFR Therapy in Gall Bladder Cancer.